Press Release December 20, 2021European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine 0 0 Share
Company Ticker News December 19, 2021Novavax Stock Pushes Higher In A Pattern: Technical Analysis 0 0 Share
Press Release December 19, 2021NVAX Investors Have Opportunity to Lead Novavax, Inc. Securities Fraud Lawsuit 0 0 Share
Company Ticker News December 19, 2021WHO Grants Novavax Covid Vaccine Emergency Use Approval As Omicron Fears Deepen 0 0 Share
Company Ticker News December 19, 2021WHO Issues Emergency Use Listing to Novavax-Serum Institute's COVID-19 Vaccine 0 0 Share
Company Ticker News December 19, 2021Is the Omicron Surge Helping These 2 Nasdaq Stocks Recover? 0 0 Share
Press Release December 19, 2021Rosen, A Leading Law Firm, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX 0 0 Share
Press Release December 3, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX 0 0 Share
